JPRN-UMIN000039091已完成未知
Additive effect of Tiotropium on Fluticasone propionate /Formoterol in patients with asthma-COPD overlap. - Additive effect of Tiotropium on Fluticasone/Formoterol in patients with ACO
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 入组人数
- 18
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 40years-old 至 99years-old（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1)Patients with unstable symptoms 2)Patients needed hospitalization because of infectious diseases 3)Patients with hospitalization within 8 weeks 4)Patients with severe hepatic or renal disease 5)Patients with uncontrolled diabes mellitus 6) Female with pregnancy 7)Female breast-feeding baby 8)Patients enrolled by clinical trials within 3 month 9)Patients recognized as insufficient
研究者
相似试验
已完成
4 期
Fluticasone Propionate/Salmeterol Combination 250/50 DISKUS in the Exercise Endurance Time in Patients With Chronic Obstructive Pulmonary DiseasePulmonary Disease, Chronic ObstructiveNCT01124422GlaxoSmithKline255
进行中（未招募）
1 期
Efficacy of Fluticasone Propionate associated With Salmeterol underwent allogeneic hematopoietic stem cell transplantatioBronchiolitis Obliterative Syndrome after hematopoietic stem cell transplantation (HSCT)..EUCTR2020-003010-12-FRASSISTANCE PUBLIQUE - HOPITAUX DE PARIS (AP-HP)243
已完成
不适用
Efficacy of Fluticasone propionate / Formoterol fumarate hydrate on human bronchial mucocillially movement using bronchoscopic specimeRespiratory disease requiring bronchoscopyJPRN-UMIN000017645Gifu Municipal Hospital20
已完成
不适用
Influence of fluticasone on the determination of saliva cortisoladrenal function10006436asthmaNL-OMON34725Medisch Centrum Leeuwarden30
已完成
不适用
Additional effects of moderate-dose fluticasone and salmeterol combination therapy on exacerbations and airflow limitations in patients with COPD in JapaCOPDJPRN-UMIN000007544Kyusyu Asthma & COPD Forum1,008